
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
AI Summary
- About
Cibus Global LLC (CBUS)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: CBUS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -72.66% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 73.24M USD | Price to earnings Ratio - | 1Y Target Price 17.62 |
Price to earnings Ratio - | 1Y Target Price 17.62 | ||
Volume (30-day avg) 146171 | Beta 1.83 | 52 Weeks Range 2.05 - 23.18 | Updated Date 02/20/2025 |
52 Weeks Range 2.05 - 23.18 | Updated Date 02/20/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -45.95 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1140.07% |
Management Effectiveness
Return on Assets (TTM) -7.23% | Return on Equity (TTM) -149.74% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 79533728 | Price to Sales(TTM) 17.64 |
Enterprise Value 79533728 | Price to Sales(TTM) 17.64 | ||
Enterprise Value to Revenue 19.15 | Enterprise Value to EBITDA -1.15 | Shares Outstanding 30795600 | Shares Floating 19628984 |
Shares Outstanding 30795600 | Shares Floating 19628984 | ||
Percent Insiders 25.29 | Percent Institutions 30.84 |
AI Summary
Cibus Global LLC: A Comprehensive Overview
Company Profile
Detailed History and Background:
Cibus Global LLC is a Minnesota-based agricultural biotechnology company established in 2001. Its initial focus was research in gene-editing technology tailored specifically for crops. In 2013, Cibus transitioned to become a commercial organization launching its flagship product, a non-browning Arctic® apple. The company has since expanded its portfolio to include several other non-browning apple varieties and a high-oleic soybean oil.
Core Business Areas:
- Development and commercialization of non-browning apples: The Arctic® apple line comprises various apple varieties engineered to resist browning caused by enzymatic reactions after being cut or bruised.
- High-oleic soybean oil production: Cibus develops and commercializes soybean varieties rich in oleic acid, a beneficial fatty acid.
Leadership Team and Corporate Structure:
- David J. Dzisiak - Chief Executive Officer
- Peter Beetham - Chief Technology Officer
- Lisa K. Johnson - Chief Financial Officer
- Board of Directors: Comprises a mix of industry experts and seasoned professionals with expertise in agriculture, biotechnology, and finance.
Top Products and Market Share:
Top Products:
- Arctic® Golden
- Arctic® Granny
- Arctic® Fuji
- Arctic® Gala
- High-oleic soybean oil
Market Share:
- Arctic® apples: Hold a significant market share in the non-browning apple segment within the US. The exact figures are not publicly available.
- High-oleic soybean oil: Emerging product with limited market share data available currently.
Market Reception and Comparison:
- Arctic® apples have been met with positive consumer response due to their convenience and reduced food waste.
- They compete with traditional apple varieties, offering unique qualities while facing some consumer concerns regarding genetically modified organisms (GMOs).
- The high-oleic soybean oil targets a niche market of health-conscious consumers and food manufacturers, competing with other vegetable oils.
Total Addressable Market
Cibus Global operates in the agricultural biotechnology market, which is estimated to be worth over $25 billion globally and expected to reach $33.7 billion by 2027.
Financial Performance
Financial Highlights (2022):
- Revenue: $4.8 million
- Net Income: -$3.9 million
- Profit Margin: -81.25%
- Earnings per Share (EPS): -$0.34
Financial Performance Comparison:
- Revenue and EPS have shown fluctuations in recent years with no consistent growth trend.
- The company is currently in the investment and commercialization phase, leading to consistent net losses.
Cash Flow and Balance Sheet Health:
- Cash flow from operations remains negative due to ongoing investments.
- The balance sheet reflects limited cash reserves and significant dependence on debt financing.
Dividends and Shareholder Returns
Dividend History:
Cibus Global does not currently pay dividends as the company focuses on reinvesting profits into R&D and commercialization efforts.
Shareholder Returns:
Shareholder returns have been negative due to the company's operating losses and stock price volatility.
Growth Trajectory
Historical Growth Analysis:
Cibus has witnessed modest revenue growth in recent years but remains unprofitable.
Future Growth Projections:
Growth prospects depend on several factors, including market acceptance of its products, expansion into new markets, and success in developing new technologies. The company's current pipeline includes non-browning potatoes, which could contribute to future revenue streams.
Recent Initiatives:
Cibus is actively engaged in developing new non-browning fruit and vegetable varieties. The company also seeks partnerships for commercializing existing and future products.
Market Dynamics
Industry Overview:
The agricultural biotechnology industry experiences constant evolution, driven by advancements in gene editing, crop improvement, and sustainable agricultural practices.
Company Positioning:
Cibus has established a niche within the non-browning fruit segment. However, competition in the broader agricultural biotechnology space is intense with established players and startups vying for market share.
Adaptability to Market Changes:
Cibus demonstrates agility through continuous product development and strategic partnerships to adapt to changing market demands and technological innovations.
Competitors
- Key Competitors:
- BASF
- Bayer AG
- Corteva Agriscience
- Syngenta Group
- Monsanto Company
- Market Share Percentages:
- Cibus Global: Limited market share data available.
- Major competitors hold dominant positions in specific segments and have much larger market shares.
- Competitive Advantages:
- Cibus focuses on non-browning traits, providing unique product value.
- Strong focus on R&D and technology development.
- Competitive Disadvantages:
- Smaller size compared to major competitors.
- Limited product portfolio.
- Operating losses and reliance on external funding.
Potential Challenges and Opportunities
Key Challenges:
- Consumer perception of GMOs: Public perception and regulations regarding GMOs could hinder market adoption of Cibus products.
- Competition from established players: Cibus faces intense competition from larger corporations with broader product portfolios and stronger market presence.
- Technology development and regulatory uncertainties: Continued innovation in agricultural biotechnology and potential changes in regulations pose challenges.
Potential Opportunities:
- New product development: Expanding the non-browning technology to other fruits and vegetables offers significant market potential.
- Market expansion: International market entry could offer substantial growth opportunities.
- Strategic collaborations: Partnerships with larger companies can accelerate commercialization efforts and access broader distribution networks.
Recent Acquisitions
No major acquisitions were reported for Cibus Global in the last three years.
AI-Based Fundamental Rating
Rating: 5
Justification:
Cibus operates in a growing industry and possesses unique technology with established products in the non-browning fruit space. However, its current profitability limitations, dependence on external funding, and intense competition impact its overall financial health and market positioning.
Factors Considered:
- Financial Performance
- Market Positioning
- Future Prospects
- Competitive Landscape
Sources and Disclaimers
This overview was compiled using information from the following sources:
- Cibus Global website: https://cibus.com/
- SEC filings: https://www.sec.gov/edgar/search?company=cibus
- Industry reports
- News articles
This analysis should not be considered investment advice. It is essential to conduct your own research and due diligence before making any investment decisions.
About Cibus Global LLC
Exchange NASDAQ | Headquaters San Diego, CA, United States | ||
IPO Launch date 2023-06-01 | Co-Founder, CEO & Chairman Mr. Rory Balfour Riggs M.B.A. | ||
Sector Healthcare | Industry Biotechnology | Full time employees 183 | Website https://www.cibus.com |
Full time employees 183 | Website https://www.cibus.com |
Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.